Record Details

Parnaparin: confronto con le altre eparine a basso peso molecolare

Farmeconomia

View Archive Info
 
 
Field Value
 
Title Parnaparin: confronto con le altre eparine a basso peso molecolare
 
Creator Pradelli, Lorenzo
 
Subject Pharmacoeconomics; Health economics
Sodium parnaparin; Low molecular weight heparin (LMWH); Thrombotic pathologies
 
Description Sodium parnaparin is a low molecular weight heparin (LMWH). The introduction of this drug class has represented a medical advancement in the prevention and therapy of thromboembolic pathologies, as they maintain the same efficacy of unfractionated heparin, but with simplified dosing regimens and reduced side effects. Parnaparin has demonstrated its thromboprophylactic efficacy on both high- and moderate risk surgical patients, besides resulting effective in treating established deep vein thromboses and thrombosis-associated phlebopathies. Alongside these clinical advantages, parnaparin and other LMWHs allow outpatient or home-based therapy of a large number of subjects that should otherwise be treated in hospital, with important savings of health resources and enhanced quality of life for the patients. In Italy, parnaparin drug acquisition cost is among the lowest in its class for many applications, permitting marginal savings in health costs at the same efficacy level. In summary, the use of parnaparin in thrombotic pathologies has very good efficacy and safety profiles, and has positive clinical and economical outcomes for patients, health system and society as a whole.
 
Publisher SEEd Medical Publishers
 
Date 2005-09-15
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
—
 
Format application/pdf
 
Identifier https://journals.edizioniseed.it/index.php/FE/article/view/837
10.7175/fe.v6i3.837
 
Source Farmeconomia. Health economics and therapeutic pathways; Vol 6, No 3 (2005); 227-241
2240-256X
 
Language eng
 
Relation https://journals.edizioniseed.it/index.php/FE/article/view/837/921
 
Rights Copyright (c) 2005 Farmeconomia. Health economics and therapeutic pathways
http://creativecommons.org/licenses/by-nc/4.0